Your Location：
Home >
Browse articles >
Construction of Evidence Body for Revision of Safety Information on Package Inserts of Chinese Patent Medicines in Post-marketing： Taking Xiaoke'an Capsules as an Example
Updated：2024-04-17
Previous|Next

    • Construction of Evidence Body for Revision of Safety Information on Package Inserts of Chinese Patent Medicines in Post-marketing： Taking Xiaoke'an Capsules as an Example

    • CHEN Zijia , QIAO Meng , LEI Chao , WANG Zhifei , XIE Yanming
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 10, Pages: 217-224(2024)

    • DOI： 10.13422/j.cnki.syfjx.20240562     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 2 )

  • References

  • Publication Info

  • Metrics

243

Views

562

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Multi-component Quality Consistency Evaluation of Leonuri Herba Granules Based on HPLC-DAD-CAD Multi-detector Technique and Chemometrics
Formulation Characteristics and Efficacy Classification of Chinese Patent Medicines for Cardiovascular and Cerebrovascular Diseases Based on Diagram of Tangye Jingfa Tu
Correlation of "Medicinal Tissue-property， Taste， and Efficacy-clinical Application" of Traditional Chinese Medicine from Plant Skin
Application and Analysis of High-quality Evaluation for Jianwei Xiaoshi Tablets
Clinical Evidence of Treatment of Constipation with Oral Chinese Patent Medicine： A Scoping Review

Related Author

LI Shuangyan
ZHANG Jun
GUO Cong
LI Siyuan
DI Jipeng
SU Jiangmin
LIU An
KOU Xiaodi

Related Institution

Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
Tianjin University of Traditional Chinese Medicine
Xiyuan Hospital， China Academy of Chinese Medical Sciences
Xuanwu Hospital， Capital Medical University
Community Health Center， Beijing Jiaotong University